The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (Germany). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of ABACUS MEDICINE A/S is being, or will be, made to the public outside Germany. The offer in Germany is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the Danish Financial Supervisory Authority (Finanstilsynet) and which has been published on the website of ABACUS MEDICINE A/S. Any investment decision regarding the publicly offered securities of ABACUS MEDICINE A/S should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from Joh. Berenberg, Gossler & Co. KG (Neuer Jungfernstieg 20, 20354 Hamburg, Germany) during regular business hours and on the website of ABACUS MEDICINE A/S (www.abacusmedicine.com/investor).
The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (United States). The shares of ABACUS MEDICINE A/S, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (the Securities Act), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. ABACUS MEDICINE A/S does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States.
The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.
The information set forth on the following web pages is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The shares from the offer are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this information or any of its contents.
We are happy to help, so please get in touch. Below you will find our main offices, but we have people covering all of Europe.
Kalvebod Brygge 35
1560 Copenhagen V
Maglódi út 6
Berliner Straße 8
282 Farnborough Road
Farnborough GU14 7NA
12/14 Rond-Point des Champs-Elysées
Paris 75008, France
1812 RC Alkmaar